News
United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...
NewYork-Presbyterian researchers have developed a deep learning model that increases doctors' abilities to diagnose ...
The development of new technology and robotic systems in cardiology is creating new possibilities in the specialty, from AI to minimally invasive surgery. Here’s what five cardiologists have told ...
Virtual echocardiography screening tool scores calculated via algorithm matched manually calculated scores and are promising ...
1d
MedPage Today on MSNFDA Panel Takes Aim at SSRI Use During Pregnancy"Serotonin may play a crucial role in the development of organs of a baby in utero, specifically heart, brain, and even the ...
When Lauren Chapple of Shavertown crossed the finish line in a New Year’s Eve 5K, she was delighted, and even a little ...
WARREN, Ohio (MyValleyTributes) – Kathleen Connelly Sweet, age 76, died Wednesday, July 16, 2025 of interstitial lung disease ...
In addition to these quarterly earnings, Merck & Co., Inc. (NYSE:MRK) has shown its resilience as a dividend stock. The ...
Increasing irisin, found at lower levels in people with PAH, may help slow disease progression by stopping vascular ...
Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...
From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...
Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results